microbiome

Microbiome Report for Week Ending 3/9/19
Microbiome Report for Week Ending 3/9/19
CP Wire
microbiome
Synlogic
AOBiome
AbbVie
Infant Bacterial Therapeutics
IBD
atopic dermatitis
Flag link:
Microbiome Report for Week Ending 3/9/19
microbiome
Flag link:
AstraZeneca lines up a $20M installment plan to launch a new oncology collaboration with microbiome player Seres
AstraZeneca lines up a $20M installment plan to launch a new oncology collaboration with microbiome player Seres
Endpoints
AstraZeneca
oncology
microbiome
Seres Therapeutics
Flag link:
Microbiome Report for Week Ending 3/2/19
Microbiome Report for Week Ending 3/2/19
CP Wire
microbiome
Axial Biotherapeutics
Azitra
Flag link:
Microbiome Report for Week Ending 3/2/19
microbiome
Axial Biotherapeutics
Azitra
Flag link:
Seventure holds first close of €200M microbiome fund
Seventure holds first close of €200M microbiome fund
Fierce Biotech
Seventure Partners
microbiome
Novartis
startups
Flag link:
Microbiome Report for Week Ending 2/16/19
Microbiome Report for Week Ending 2/16/19
CP Wire
microbiome
SkinBio Therapeutics
Flag link:
Microbiome Report for Week Ending 2/16/19
microbiome
SkinBio Therapeutics
Flag link:
Microbiome Company Kaleido Biosciences Announces $120 Million IPO
Microbiome Company Kaleido Biosciences Announces $120 Million IPO
CP Wire
Kaleido Biosciences
microbiome
IPOs
Flag link:
Microbiome Report for Week Ending 2/9/19
Microbiome Report for Week Ending 2/9/19
CP Wire
microbiome
Seres Therapeutics
Kallyope
Flag link:
Microbiome Report for Week Ending 2/9/19
microbiome
Seres Therapeutics
Kallyope
Flag link:
Investigational Live Microbial Drug Granted Breakthrough Therapy Designation for Recurrent C. Difficile
Investigational Live Microbial Drug Granted Breakthrough Therapy Designation for Recurrent C. Difficile
CP Wire
Finch Therapeutics
CP101
C. difficile
microbiome
Flag link:
Investigational Live Microbial Drug Granted Breakthrough Therapy Designation for Recurrent C. Difficile
Finch Therapeutics
CP101
C. difficile
microbiome
Flag link:
Microbiome Report for Week Ending 2/2/19
Microbiome Report for Week Ending 2/2/19
CP Wire
microbiome
Azitra
Evelo Biosciences
4D Pharma
SkinBio Therapeutics
Flag link:
Microbiome Report for Week Ending 2/2/19
microbiome
Azitra
Evelo Biosciences
4D Pharma
SkinBio Therapeutics
Flag link:
Configure Azitra Completes Enrollment in Clinical Trial of Topical Commensal Microbiological Agent
Configure Azitra Completes Enrollment in Clinical Trial of Topical Commensal Microbiological Agent
CP Wire
Azitra
AZT-04
microbiome
Flag link:
Azitra Completes Enrollment in Clinical Trial of Topical Commensal Microbiological Agent
Azitra
AZT-04
microbiome
Flag link:
Microbiome Report for Week Ending 1/26/19
Microbiome Report for Week Ending 1/26/19
CP Wire
microbiome
Second Genome
Vedanta Biosciences
NASH
Immune Biotech
Flag link:
Vedanta Biosciences Publishes Seminal Research in Leading Scientific Journal Regarding its Immuno-oncology Candidate, VE800
Vedanta Biosciences Publishes Seminal Research in Leading Scientific Journal Regarding its Immuno-oncology Candidate, VE800
CP Wire
Vedanta Biosciences
VE800
immuno-oncology
microbiome
Flag link:
Vedanta Biosciences Publishes Seminal Research in Leading Scientific Journal Regarding its Immuno-oncology Candidate, VE800
Vedanta Biosciences
VE800
immuno-oncology
microbiome
Flag link:

Pages